Physician

Winston Canute Vaughan, M.D.

According to 2025 Medicare claims, Winston Vaughan, M.D. (NPI: 1821182973) practices otolaryngology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Mateo, CA. This provider's primary affiliated billing organization is BASS MEDICAL GROUP (NPI: 1154401941; TIN: 562605608) and primary practice location at 94027-3802. Vaughan is affiliated with the Privia Quality Network Tennessee, LLC (ACO ID: A4943), participating under the MSSP model.

Vaughan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 664 traditional Medicare patients, billed 3,317 HCPCS/CPT codes, and received $475,725 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 510 prescription claims across 214 beneficiaries totaling $43,955 in drug costs, led by Ipratropium Bromide (Ipratropium Bromide). DME data shows 193 claims. Open Payments data shows 6 records totaling $12,755. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $79,032 to $43,955. In contrast, DME billing represents a smaller volume and rose steadily, from $4,800 to $9,169.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	547	3,117	$481,109
2016	544	3,438	$477,891
2017	508	3,248	$445,725
2018	523	3,215	$435,534
2019	586	3,398	$452,185
2020	495	2,384	$309,051
2021	485	2,639	$379,519
2022	553	3,038	$416,179
2023	623	3,234	$440,907
2024	664	3,317	$475,725

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	188	890	$79,032
2016	181	727	$75,420
2017	147	417	$37,369
2018	133	308	$19,264
2019	181	477	$45,883
2020	131	377	$41,386
2021	162	404	$52,776
2022	149	330	$30,385
2023	173	376	$25,279
2024	214	510	$43,955

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	65	194	$19,856
2016	44	172	$12,827
2017	13	71	$4,377
2018	N/R	55	$3,638
2019	N/R	146	$5,832
2020	N/R	105	$3,431
2021	N/R	104	$3,524
2022	N/R	178	$5,848
2023	N/R	92	$2,718
2024	37	193	$7,620

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	629	1,481	$180
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	71	71	$150
70486	Ct scan of face without contrast	78	86	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	223	344	$121
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	522	1,140	$85

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ipratropium Bromide	Ipratropium Bromide	52	2,169	$1,628
Azelastine Hcl	Azelastine Hcl	21	1,240	$729
Doxycycline Hyclate	Doxycycline Hyclate	50	644	$565
Methylprednisolone	Methylprednisolone	55	329	$387
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	604	$373

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	47	$1,407
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	15	$1,249
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	24	$1,228
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	16	$1,182
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	13	31	$1,159

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$12,755	Neurent Medical Limited
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Winston Canute Vaughan, M.D.?

Tedicare shows public-source Medicare data for Winston Canute Vaughan, M.D. (NPI 1821182973), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Winston Canute Vaughan, M.D. have ACO affiliation data?

Winston Canute Vaughan, M.D. is shown with ACO affiliation data for Privia Quality Network Tennessee, LLC (MSSP, ACO ID A4943).

What billing organization is linked to Winston Canute Vaughan, M.D.?

Winston Canute Vaughan, M.D. is linked to BASS MEDICAL GROUP (billing NPI 1154401941) in the available physician profile data.

Does Winston Canute Vaughan, M.D. have Open Payments data?

Winston Canute Vaughan, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.